Cargando…

Editorial: Advances in drug-induced diseases

Detalles Bibliográficos
Autores principales:	Liu, Yao, Wang, Jia-bo, Zeng, Linan, Gossell-Williams, Maxine, Moriel, Patricia, Yan, Miao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128033/ https://www.ncbi.nlm.nih.gov/pubmed/37113756 http://dx.doi.org/10.3389/fphar.2023.1193099

Ejemplares similares

Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
por: Gossell-Williams, Maxine, et al.
Publicado: (2022)

Influence of Jamaican Cultural and Religious Beliefs on Adherence to Pharmacotherapy for Non-Communicable Diseases: A Pharmacovigilance Perspective
por: Brown, Robyn, et al.
Publicado: (2022)

Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis
por: Thomas-Brown, Peta-Gaye L., et al.
Publicado: (2018)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: Advancements in computational studies of drug toxicity
por: Flynn, Noah R., et al.
Publicado: (2023)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

Editorial: Advanced nanotechnological detection and drug delivery configurations
por: Hashemi, Seyyed Alireza, et al.
Publicado: (2023)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery
por: Exner, Agata A., et al.
Publicado: (2022)

Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
por: Mehta, Piyush Pradeep, et al.
Publicado: (2023)

Editorial: Pharmacokinetics of herbal medicines and herb-drug interactions
por: Jia, Wei-Wei, et al.
Publicado: (2022)

Editorial: Advanced chemical and material tools to enhance the therapeutic effect of drugs
por: Ihsan, Ayesha, et al.
Publicado: (2023)

Editorial: structural plasticity induced by drugs of abuse
por: Olive, M. Foster, et al.
Publicado: (2015)

The prevalence of major potential drug-drug interactions at a University health centre pharmacy in Jamaica
por: Kennedy-Dixon, Tracia-Gay, et al.
Publicado: (2015)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Editorial: Drugging p53 for non-cancer diseases
por: Jiang, Fan, et al.
Publicado: (2022)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Accessibility of Medicines for Children: A Systematic Review
por: Chen, Zhe, et al.
Publicado: (2021)

The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica
por: Gossell-Williams, Maxine, et al.
Publicado: (2008)

Editorial: Bone targeting nanoparticle drug delivery system in bone metabolism and bone-related tumor diseases
por: Wang, Xing, et al.
Publicado: (2022)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Research advances in treatment methods and drug development for rare diseases
por: Han, Qiaoqiao, et al.
Publicado: (2022)

Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic
por: Wang, Jia-bo, et al.
Publicado: (2021)

Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica
por: Condappa, Andrew, et al.
Publicado: (2018)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Editorial: Recent Advances in Cardiotoxicity Testing
por: Mohamed, Tamer M. A., et al.
Publicado: (2021)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gors2kfnukb5pqdcn8kl2nhfl6